MyAverix Finance
US · Healthcare
Coya Therapeutics, Inc. Common Stock (COYA)
Biotechnology
Coya Therapeutics, Inc. Common Stock (COYA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for COYA
Coya Therapeutics, Inc. Common Stock (COYA) — FAQ
What is COYA's P/E ratio?
The price-to-earnings (P/E) ratio for Coya Therapeutics, Inc. Common Stock (COYA) is 25.00 (data as of 2026-05-23).
Does Coya Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Coya Therapeutics, Inc. Common Stock (COYA). Check the MyAverix Finance app for the latest dividend data.
What sector is Coya Therapeutics, Inc. Common Stock in?
Coya Therapeutics, Inc. Common Stock (COYA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is COYA listed on?
COYA is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.